Brekke I B, Sødal G, Jakobsen A, Bentdal O, Pfeffer P, Albrechtsen D, Flatmark A
Department of Surgery B, National Hospital, Oslo, Norway.
Eur J Vasc Surg. 1992 Sep;6(5):471-6. doi: 10.1016/s0950-821x(05)80619-x.
Over a 16-year period (1973-1989), 63 renal autotransplants were performed in 59 patients for fibro-muscular dysplasia (FMD) with renal artery stenoses (42 kidneys) or aneurysms (21 kidneys). About two-thirds of the autotransplants were performed before percutaneous transluminal angioplasty (PTA) was established for clinical use. However, vascular disease at a site or type not suitable for PTA was present in 57 (90%) of the kidneys. Hypertension was the leading symptom in 56 patients, including four in whom renal autotransplantation was performed as an emergency for acute renal artery occlusion or malignant hypertension. Blood pressure returned to normal or improved in 51 (91%) and remained unchanged in five patients (9%) following autotransplantation. Three patients with renal artery aneurysm in whom haematuria and loin pain were the indications for treatment, became asymptomatic following surgical intervention. Bilateral renal autotransplantation was performed synchronously in one and sequentially in three patients. There were no operative deaths, but two kidneys were lost postoperatively in two 2-year-old children owing to renal vascular thrombosis. In the follow-up period (mean 4.3 years), one additional kidney was lost at 3 months owing to progressive FMD. Blood pressure and renal function remained stable in all other patients. Based on the excellent results achieved in this series, it is concluded that extracorporeal vascular repair and renal autotransplantation is a safe procedure for the patient as well as the kidney affected by FMD. The procedure is advocated as an alternative to in situ reconstruction in patients with renal artery disease not accessible to PTA, such as aneurysms and complex branch renal artery stenoses.
在16年期间(1973 - 1989年),59例患者共进行了63例自体肾移植,用于治疗伴有肾动脉狭窄(42个肾脏)或动脉瘤(21个肾脏)的纤维肌发育不良(FMD)。约三分之二的自体肾移植是在经皮腔内血管成形术(PTA)用于临床之前进行的。然而,57个(90%)肾脏存在不适合PTA的部位或类型的血管疾病。高血压是56例患者的主要症状,其中4例因急性肾动脉闭塞或恶性高血压而作为急诊进行了自体肾移植。自体肾移植后,51例(91%)患者的血压恢复正常或改善,5例(9%)患者的血压保持不变。3例以血尿和腰痛为治疗指征的肾动脉动脉瘤患者,手术干预后无症状。1例患者同期进行了双侧自体肾移植,3例患者分期进行。无手术死亡病例,但2例2岁儿童术后因肾血管血栓形成而失去了2个肾脏。在随访期(平均4.3年),1个肾脏在3个月时因进行性FMD而丢失。所有其他患者的血压和肾功能保持稳定。基于本系列取得的优异结果,得出结论:体外血管修复和自体肾移植对受FMD影响的患者和肾脏来说是一种安全的手术。对于无法进行PTA的肾动脉疾病患者,如动脉瘤和复杂的肾动脉分支狭窄患者,提倡将该手术作为原位重建的替代方法。